Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Didu New Materials is a Chinese chemical enterprise specializing in the research, development, and production of pharmaceutical intermediates and fine chemicals. Based in Xi'an, the company provides a wide range of products including active pharmaceutical ingredients (APIs), organic synthesis blocks, and specialty chemicals for the global life sciences industry. Their portfolio frequently features compounds such as tianeptine, phenibut, and various heterocyclic intermediates used in drug synthesis. The company operates primarily as a supplier and contract manufacturer, supporting pharmaceutical companies and research institutions with high-purity chemical materials. They maintain a strong focus on export markets, providing custom synthesis services to meet specific client requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Didu New Materials.